NEW YORK, September 9, 2004 - Many cancers, including colon, prostate, and leukemia, continue to grow unchecked because they do not respond to a signal to die and stop proliferating from Transforming Growth Factor-beta (TGF-b). The cause of this signaling disruption of the normal cell cycle has not been fully understood. For the first time, scientists at Memorial Sloan-Kettering Cancer Center have discovered the biologic function of the cytoplasmic form of the Promyelocytic Leukemia protein (PML), and identified it as an essential factor in maintaining TGF-b signaling. Their findings, published in the September 9 issue of the journal Nature, explain the link between these two proteins in the development of cancer and suggest that restoring their activity may provide a possible cancer treatment.
"Through our discovery of the biologic function of PML and its essential role in maintaining TGF-b signaling, we can better understand the progression of many human cancers," said Pier Paolo Pandolfi, M.D., Ph.D., Head of the Molecular and Developmental Biology Laboratory at Memorial Sloan-Kettering and the study's senior author. "Restoring PML function may correct this signaling defect therefore providing a novel therapeutic target for cancer drugs."
TGF-b is a protein that can suppress tumor development by signaling a cell to stop growing. The unresponsiveness to TGF-b signaling has been associated with a variety of human cancers. In addition to this loss of TGF-b, loss of PML is associated with tumor progression in many human cancers, including prostate, breast, colon, and lung, as shown by Dr. Pandolfi and colleagues in a recently published study in the Journal of the National Cancer Institute. In a later work published in Nature Cell Biology, they also demonstrated an unexpected role for PML in affecting the nucleolar network for tumor suppression and in regulating the function of a gene crucial to the suppression of the genesis of cancer.
'"/>
Contact: Joanne Nicholas
mediastaff@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
8-Sep-2004
Page: 1 2 Related biology news :1.
New molecular link key to cellular proteins involved in cancer progression, other diseases2.
Researchers identify protein promoting vascular tumor growth3.
UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies4.
Experimental drug shown to block mutant protein causing blood disease5.
Loss of the neuronal adhesion protein d-catenin leads to severe cognitive dysfunction6.
Images of tail of protein needed for cell multiplication suggest anticancer drug targets7.
New dye directly reveals activated proteins in living cells8.
Disruption of protein-folding causes neurodegeneration, mental retardation9.
Optimizing proteins death domain halts leukemia in laboratory study10.
Stuck on you: Scientists lay bare secrets of bacterial attachment proteins11.
Scientists discover proteins involved in spread of HIV-1 infection